Filing Flows › Zenas BioPharma (ZBIO) › Stock forecast & fair value
Zenas BioPharma (ZBIO) stock forecast and price target
Zenas BioPharma (ZBIO) trades at $28.26. 8 analysts' median price target is $46.50 (+65%), from $32.00 to $59.00.
Zenas BioPharma's latest quarter
Zenas BioPharma, Q3 2026: revenue $10.0M, net loss $109M, operating cash flow −$58.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for ZBIO stock?
The median of 8 analysts' 12-month targets is $46.50, +65% from $28.26; the range is $32.00 to $59.00. The average rating is strong buy.
Does Zenas BioPharma usually beat earnings estimates?
It beat the consensus EPS estimate in 40% of the quarters on record.
Is ZBIO stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.